Rafferty Asset Management, LLC Coherus Bio Sciences, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.74 - $5.45 $3.28 Million - $4.78 Million	876,332 New	876,332 $3.28 Million
Q1 2023 May 11, 2023	SELL	$5.89 - $10.52 $405,308 - $723,912	-68,813 Reduced 14.66%	400,569 $2.74 Million
Q4 2022 Feb 13, 2023	BUY	$5.69 - $10.07 $1.14 Million - $2.02 Million	200,546 Added 74.6%	469,382 $3.72 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $277,694 - $537,185	38,730 Added 16.83%	268,836 $2.58 Million
Q2 2022 Aug 12, 2022	SELL	$5.86 - $13.23 $247,180 - $558,054	-42,181 Reduced 15.49%	230,106 $1.67 Million
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $991,972 - $1.49 Million	90,840 Added 50.06%	272,287 $3.52 Million
Q4 2021 Feb 10, 2022	BUY	$15.81 - $18.99 $908,410 - $1.09 Million	57,458 Added 46.34%	181,447 $2.9 Million
Q3 2021 Nov 10, 2021	SELL	$12.68 - $17.79 $708,888 - $994,567	-55,906 Reduced 31.08%	123,989 $1.99 Million
Q2 2021 Aug 10, 2021	SELL	$12.95 - $15.41 $325,705 - $387,576	-25,151 Reduced 12.27%	179,895 $2.49 Million
Q1 2021 May 10, 2021	BUY	$14.42 - $21.39 $2.35 Million - $3.48 Million	162,719 Added 384.43%	205,046 $3 Million
Q4 2020 Feb 10, 2021	SELL	$16.56 - $18.94 $970,896 - $1.11 Million	-58,629 Reduced 58.07%	42,327 $736,000
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $723,751 - $826,847	41,571 Added 70.0%	100,956 $1.85 Million
Q2 2020 Aug 07, 2020	BUY	$14.43 - $19.16 $656,911 - $872,239	45,524 Added 328.43%	59,385 $1.06 Million
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $1.43 Million - $2.76 Million	-122,540 Reduced 89.84%	13,861 $225,000
Q4 2019 Feb 10, 2020	SELL	$16.33 - $21.37 $303,003 - $396,520	-18,555 Reduced 11.97%	136,401 $2.46 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $828,040 - $1.19 Million	50,800 Added 48.77%	154,956 $3.14 Million
Q2 2019 Aug 09, 2019	BUY	$13.1 - $22.1 $168,911 - $284,957	12,894 Added 14.13%	104,156 $2.3 Million
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $764,775 - $1.41 Million	91,262 New	91,262 $1.25 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$17.8 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$16.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.77 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.49 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account